TimesSquare Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-697,265
Closed -$46.7M 159
2024
Q3
$46.7M Sell
697,265
-7,215
-1% -$592K 0.7% 55
2024
Q2
$79.9M Sell
704,480
-10,200
-1% -$1.29M 1.26% 23
2024
Q1
$99.1M Sell
714,680
-53,910
-7% -$6.78M 1.44% 13
2023
Q4
$95.4M Buy
768,590
+35,210
+5% +$3.6M 1.4% 15
2023
Q3
$68.4M Buy
733,380
+726,980
+11,359% +$81.9M 1.07% 25
2023
Q2
$822K Sell
6,400
-200
-3% -$24.2K 0.01% 169
2023
Q1
$767K Buy
6,600
+300
+5% +$33.6K 0.01% 173
2022
Q4
$713K Sell
6,300
-1,700
-21% -$187K 0.01% 174
2022
Q3
$644K Buy
+8,000
New +$678K 0.01% 186
2019
Q2
Sell
-967,200
Closed -$28.8M 227
2019
Q1
$28.8M Sell
967,200
-947,200
-49% -$33.3M 0.22% 155
2018
Q4
$57.3M Buy
1,914,400
+59,600
+3% +$1.89M 0.49% 85
2018
Q3
$66.3M Buy
+1,854,800
New +$57.5M 0.44% 88

Other funds holding DXCM